Pricing Log in Create free account

DiaMedica Therapeutics, Inc. (DMAC) vs Electra Therapeutics Inc. (ETRA)

DiaMedica Therapeutics, Inc. and Electra Therapeutics Inc. are both Biotechnology companies. DiaMedica Therapeutics, Inc. and Electra Therapeutics Inc. are of similar size ($504.7M and $489.6M).

Valuation

Metric DMAC ETRA Biotechnology median
P/E n/m — 10.60
P/S n/m — 9.40
P/B 13.16 — 2.13
Price to free cash flow n/m — 25.18
EV/EBITDA n/m — 0.66
EV/Sales n/m — 9.02
Earnings yield (7.69%) — (32.88%)
Free cash flow yield (6.25%) — (23.13%)

Profitability

Metric DMAC ETRA Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (114.62%) — (51.96%)
Return on assets (98.18%) — (46.06%)
Return on invested capital 0.00% — 0.00%

Growth

Metric DMAC ETRA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (16.67%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DMAC ETRA Biotechnology median
Debt to equity 0.00 — 0.00
Current ratio 6.72 — 4.97
Net debt to EBITDA 1.70 — 1.01

Dividend

Metric DMAC ETRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DMAC ETRA Biotechnology median
Market cap 504.74m 489.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack